aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
3.320
+0.005 (0.15%)
At close: Oct 29, 2024, 4:00 PM
3.430
+0.110 (3.31%)
After-hours: Oct 29, 2024, 7:52 PM EDT

aTyr Pharma Statistics

Total Valuation

aTyr Pharma has a market cap or net worth of $251.64 million. The enterprise value is $186.83 million.

Market Cap 251.64M
Enterprise Value 186.83M

Important Dates

The next estimated earnings date is Thursday, November 7, 2024.

Earnings Date Nov 7, 2024
Ex-Dividend Date n/a

Share Statistics

aTyr Pharma has 75.80 million shares outstanding. The number of shares has increased by 65.08% in one year.

Shares Outstanding 75.80M
Shares Change (YoY) +65.08%
Shares Change (QoQ) +9.39%
Owned by Insiders (%) 2.62%
Owned by Institutions (%) 63.50%
Float 68.77M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 3.08
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 317.74
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 7.63, with a Debt / Equity ratio of 0.17.

Current Ratio 7.63
Quick Ratio 6.77
Debt / Equity 0.17
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -61.76% and return on invested capital (ROIC) is -36.06%.

Return on Equity (ROE) -61.76%
Return on Assets (ROA) -32.74%
Return on Capital (ROIC) -36.06%
Revenue Per Employee $9,966
Profits Per Employee -$981,305
Employee Count 59
Asset Turnover 0.00
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +176.67% in the last 52 weeks. The beta is 1.21, so aTyr Pharma's price volatility has been higher than the market average.

Beta (5Y) 1.21
52-Week Price Change +176.67%
50-Day Moving Average 2.14
200-Day Moving Average 1.86
Relative Strength Index (RSI) 81.98
Average Volume (20 Days) 1,574,280

Short Selling Information

The latest short interest is 1.07 million, so 1.41% of the outstanding shares have been sold short.

Short Interest 1.07M
Short Previous Month 1.36M
Short % of Shares Out 1.41%
Short % of Float 1.55%
Short Ratio (days to cover) 1.47

Income Statement

In the last 12 months, aTyr Pharma had revenue of $588,000 and -$57.90 million in losses. Loss per share was -$0.91.

Revenue 588,000
Gross Profit -49.82M
Operating Income -62.53M
Pretax Income -53.93M
Net Income -57.90M
EBITDA -61.82M
EBIT -62.53M
Loss Per Share -$0.91
Full Income Statement

Balance Sheet

The company has $78.48 million in cash and $13.85 million in debt, giving a net cash position of $64.63 million or $0.85 per share.

Cash & Cash Equivalents 78.48M
Total Debt 13.85M
Net Cash 64.63M
Net Cash Per Share $0.85
Equity (Book Value) 81.42M
Book Value Per Share 1.08
Working Capital 78.46M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$63.45 million and capital expenditures -$599,000, giving a free cash flow of -$64.05 million.

Operating Cash Flow -63.45M
Capital Expenditures -599,000
Free Cash Flow -64.05M
FCF Per Share -$0.85
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -10,633.50%
Pretax Margin -9,846.26%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin -9,860.88%

Dividends & Yields

aTyr Pharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -65.08%
Shareholder Yield -65.08%
Earnings Yield -23.01%
FCF Yield -25.45%

Analyst Forecast

The average price target for aTyr Pharma is $19.25, which is 479.82% higher than the current price. The consensus rating is "Strong Buy".

Price Target $19.25
Price Target Difference 479.82%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) 315.62%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on July 1, 2019. It was a reverse split with a ratio of 0.0714285:1.

Last Split Date Jul 1, 2019
Split Type Reverse
Split Ratio 0.0714285:1

Scores

aTyr Pharma has an Altman Z-Score of -5.2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -5.2
Piotroski F-Score n/a